Swipe om te navigeren naar een ander artikel
An Internet-based tool for reporting and analysing patient-reported outcomes (PROs) has been developed. The tool enables merging PROs with blood test results and allows for computation of treatment responses. Data may be visualized by graphical analysis and may be exported for downstream statistical processing. The aim of this study was to investigate, whether patients with myeloproliferative neoplasms (MPNs) were willing and able to use the tool and fill out questionnaires regularly.
Participants were recruited from the outpatient clinic at the Department of Haematology, Roskilde University Hospital, Denmark. Validated questionnaires that were used were European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30, Myeloproliferative Neoplasm Symptom Assessment Form, Brief Fatigue Inventory and Short Form 36 Health Survey. Questionnaires were filled out ≥6 months online or on paper according to participant preference. Regularity of questionnaire submission was investigated, and participant acceptance was evaluated by focus-group interviews.
Of 135 invited patients, 118 (87 %) accepted participation. One hundred and seven participants (91 %) preferred to use the Internet-based tool. Of the 118 enrolled participants, 104 (88 %) submitted PROs regularly ≥6 months. The focus-group interviews revealed that the Internet-based tool was well accepted.
The Internet-based approach and regular collection of PROs are well accepted with a high participation rate, persistency and adherence in a population of MPN patients. The plasticity of the platform allows for adaptation to patients with other medical conditions.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Snyder, C. F., Wu, A. W., Miller, R. S., Jensen, R. E., Bantug, E. T., & Wolff, A. C. (2011). The Role of Informatics in Promoting Patient-Centered Care. Cancer Journal, 17(4), 211–218. CrossRef
Novik, A., Salek, S., & Ionova, T. (2012). Patient-reported outcomes in patients with hematological disorders: Conceptual issues. In A. Novik, S. Salek, & T. Ionova (Eds.), Guidelines patient-reported outcomes in hematology (pp. 19–22). Genoa: Forum service editore.
Coates, A., Thomson, D., McLeod, G. R., Hersey, P., Gill, P. G., Olver, I. N., et al. (1993). Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. European Journal of Cancer, 29A(12), 1731–1734. CrossRefPubMed
Skov, V., Thomassen, M., Riley, C. H., Jensen, M. K., Bjerrum, O. W., Kruse, T. A., et al. (2012). Gene expression profiling with the principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis. Experimental Hematology, 40(9), 771–780. CrossRefPubMed
Emanuel, R. M., Dueck, A. C., Geyer, H. L., Kiladjian, J. J., Slot, S., Zweegman, S., et al. (2012). Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. Journal of Clinical Oncology, 30(33), 4098–4103. CrossRefPubMed
McMahon, B., & Stein, B. L. (2013). Thrombotic and bleeding complications in classical myeloproliferative neoplasms. Seminars in Thrombosis and Hemostasis, 39(1), 101–111. PubMed
Abelsson, J., Andréasson, B., Samuelsson, J., Hultcrantz, M., Ejerblad, E., Johansson, B., et al. (2013). Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms. Leukaemia & Lymphoma, 54(10), 2226–2230. CrossRef
Johansson, P., Mesa, R. A., Scherber, R., Abelsson, J., Samuelsson, J., Birgegaard, G., et al. (2012). Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms. Leukaemia & Lymphoma, 53(3), 441–444. CrossRef
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. http://groups.eortc.be/qol/eortc-qlq-c30. Last assessed June 2015.
Short Form 36 Health Survey. http://www.sf-36.org/tools/SF36.shtml. Last assessed June 2015.
European Organisation for Research and Treatment of Cancer Questionnaire Translation Manual. http://groups.eortc.be/qol/manuals. Last assessed June 2015.
Satu, E., & Kyngäs, H. (2008). The qualitative content analysis process. Journal of Advanced Nursing, 62(1), 107–115. CrossRef
Catanzaro, M. (1988). Using qualitative analytical techniques. In N. F. Woods & M. Catanzaro (Eds.), Nursing research: Theory and practice. C.V. Mosby: St Louis, MO.
Bush, N., Donaldson, G., Moinpour, C., Haberman, M., Milliken, D., Markle, V., et al. (2005). Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation. Quality of Life Research, 14(1), 77–93. CrossRefPubMed
Hjollund, N. H. I., Larsen, L. P., Biering, K., Johnsen, S. P., Riiskjær, E., & Schougaard, L. M. (2014). Use of patient-reported outcome (PRO) measures at group and patient Levels: Experiences from the generic integrated PRO system, WestChronic. Interactive Journal of Medical Research,. doi: 10.2196/ijmr.2885. PubMedPubMedCentral
Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., et al. (2013). ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Quality of Life Research, 22(8), 1889–1905. CrossRefPubMed
- A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms
Esben Meulengracht Flachs
Hans Carl Hasselbalch
Christen Lykkegaard Andersen
- Springer International Publishing